CPT 11102 - Tangential skin biopsy
Medicare documentation, audit risk, and billing facts.
For small physician practices, CPT 11102 represents a high - volume but high - risk coding category due to its proximity to shave removal services. The fundamental distinction lies in the clinician's intent. If the primary goal of the procedure is the complete removal of a lesion for therapeutic purposes, the shave removal series (11300 - 11313) is typically appropriate. However, if the procedure is performed to obtain a tissue sample for pathological diagnosis, CMS article A57113 mandates the use of the tangential biopsy code family. Small practices frequently fail audits when they default to shave removal codes for higher reimbursement while the medical record only supports a diagnostic intent.
The global period for CPT 11102 is 0 days, which creates a specific audit trap regarding evaluation and management (E/M) services. Under Medicare rules, the work of the biopsy includes the routine assessment of the site and the procedure itself. To bill a separate E/M code on the same day, the provider must append Modifier 25 and provide clear evidence of a significant, separately identifiable service. This means the documentation must reflect work beyond what was necessary to decide to perform the biopsy. Auditors specifically look for boilerplate notes where the E/M content is simply a copy - paste of the biopsy indications without unique clinical findings.
Documentation must be surgical in its precision to survive a contractor review. The record needs to explicitly state the diagnostic intent, the technique used, and the responsible clinician. Furthermore, the ICD - 10 - CM code must align with the suspected diagnosis documented at the time of the encounter. Many practices lose revenue during recoupments because they lack a centralized compliance system to verify these links before submission. Maintaining a robust medical record that identifies the specific lesion site and specimen handling is the only defense against the assumption of bundling by CMS contractors.
Audit traps
- Modifier 25 Routine UsageCMS auditors flag practices that automatically append Modifier 25 to every biopsy visit. You must document a separate medical necessity that is distinct from the evaluation of the biopsied lesion.
- Shave Removal vs. Biopsy IntentSelecting 11300 - 11313 for higher reimbursement when the documentation describes a diagnostic biopsy is a major compliance risk. The sole intent of obtaining a diagnosis mandates the 11102 code family.
- Inadequate Site IdentificationFailing to specify the exact lesion site and technique in the medical record leads to denials during post - payment reviews. Auditors require precise identification of the site, clinician, and specimen handling process.
- Lack of Diagnostic Intent StatementDocumentation that fails to explicitly state the diagnostic intent or the rule out diagnosis often results in the procedure being reclassified as an elective removal. Ensure the diagnostic purpose is stated clearly in the procedural note.
Unjustified Modifier 25 usage is the #1 reason CPT 11102 gets audited. d3rx's Compliance Binder identifies documentation gaps before submission. -> Protect your revenue
Build your Compliance Binder →FAQ
- Is an E/M service included in CPT 11102?
- Yes, the routine evaluation of the lesion and the decision to perform the biopsy are included. You can only bill an E/M (99202 - 99215) with Modifier 25 if you address a separate medical issue.
- What documentation is required for the biopsy site?
- You must clearly identify the specific anatomical location of the lesion. Vague descriptions like skin lesion are insufficient for audit defense; use specific coordinates or markers.
- Can 11102 be billed with shave removal codes?
- No, if the sole intent is diagnostic, use 11102. If you are performing a therapeutic shave removal, the biopsy is bundled and not separately billable.
- Does CPT 11102 have a 10 - day global period?
- No, CPT 11102 has a 0 - day global period. This means there are no post - operative days included, but the pre - operative work is bundled into the procedure payment.
- Should I report pathology separately?
- Yes, the histopathologic examination of the specimen is reported using separate codes from the 88300 series. CPT 11102 only covers the technical performance of obtaining the sample.